Showing results (41-50 of 141) with videos related to
Sort By:
Pageof 15
Clinical Pharmacokinetics|July 1, 1991
Clinical pharmacokinetics of propafenoneJ T Hii, H J Duff, E D BurgessProgress in Cardiovascular Diseases|March 1, 1996
Is a baseline electrophysiologic study mandatory for the management of patients with spontaneous, sustained, ventricular tachyarrhythmias?L B Mitchell, L S GettesInternational Journal of Cardiology|November 1, 1986
A haemodynamic study of the effects of combined slow-calcium channel blockade (nisoldipine) and beta-blockade (metoprolol) in coronary heart diseaseB Silke, S P Verma, K A Midtbo, et al.American Heart Journal|June 1, 1985
The effects on left ventricular performance of verapamil and metoprolol singly and together in exercise-induced angina pectorisB Silke, S P Verma, G I Nelson, et al.Postgraduate Medical Journal|January 1, 1984
Haemodynamic effects of nicardipine in acute myocardial infarctionB Silke, S P Verma, M Hafizullah, et al.Journal of Cardiovascular Pharmacology|January 1, 1986
Haemodynamic dose-response effects of intravenous indoramin in acute heart failure complicating myocardial infarctionB Silke, G I Nelson, S P Verma, et al.Herz|December 1, 1986
A haemodynamic dose finding study with a new slow-calcium channel blocker (amlodipine) in coronary artery diseaseM A Frais, B Silke, S P Verma, et al.European Journal of Clinical Pharmacology|January 1, 1986
Pharmacokinetic, haemodynamic and radionuclide studies with nicardipine in coronary artery diseaseB Silke, D J Graham, S P Verma, et al.Hepato-Gastroenterology|August 1, 1985
Serum gamma-aminobutyric acid (GABA) levels in patients with hepatic encephalopathyG Y Minuk, A Winder, E D Burgess, et al.Clinical Pharmacology and Therapeutics|October 1, 1987
Comparative hemodynamic dose-response effects of five slow calcium channel-blocking agents in coronary artery diseaseB Silke, M A Frais, K A Midtbo, et al.Pageof 15